ApprovalTrail

Approval · Notice of Compliance 20405 · 2018

LONSURF: Notice of Compliance 20405

Issued January 25, 2018

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
20405
Date
January 25, 2018
Company
Taiho Pharma Canada, Inc.Oakville, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Priority-NAS

Products in this notice

BrandDINStatus today
LONSURF02472104Marketed
LONSURF02472112Marketed

Medicinal ingredients